Central nervous system viral invasion and inflammation during acute HIV infection

Journal of Infectious Diseases

Volumn 206, Issue 2, 2012, Pages 275-282

  Valcour, Victor ^a   Chalermchai, Thep ^b   Sailasuta, Napapon ^c   Marovich, Mary ^d   Lerdlum, Sukalaya ^e,f   Suttichom, Duanghathai ^b   Suwanwela, Nijasri C ^e,f   Jagodzinski, Linda ^d   Michael, Nelson ^d   Spudich, Serena ^g   Van Griensven, Frits ^h,i   De Souza, Mark ^j   Kim, Jerome ^e,f   Ananworanich, Jintanat ^b,e,k,l  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b THAI RED CROSS AIDS RESEARCH CENTRE   (Thailand)

^c HUNTINGTON MEDICAL RESEARCH INSTITUTES   (United States)

^d WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^e CHULALONGKORN UNIVERSITY   (Thailand)

^f KING CHULALONGKORN MEMORIAL HOSPITAL   (Thailand)

^g YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h MINISTRY OF PUBLIC HEALTH   (Thailand)

ⁱ CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^j Armed Forces Research Institute of Medical Sciences US Component   (United States)

^k Armed Forces Research Institute of Medical Sciences San Francisco   (United States)

^l THAI RED CROSS AIDS RESEARCH CENTRE   (Thailand)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON INDUCIBLE PROTEIN 10; MONOCYTE CHEMOTACTIC PROTEIN 2; NEOPTERIN; VIRUS RNA;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CENTRAL NERVOUS SYSTEM INFECTION; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEADACHE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; NEUROLOGY; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PLEOCYTOSIS; PRIORITY JOURNAL; RISK FACTOR; VIRUS TRANSMISSION;

ACUTE DISEASE; ADULT; CENTRAL NERVOUS SYSTEM INFECTIONS; FEMALE; HIV INFECTIONS; HUMANS; INFLAMMATION; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; RNA, VIRAL; YOUNG ADULT;

EID: 84862885694     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jis326     Document Type: Article

References (32)

1. Heaton RK, Clifford DB, Franklin DR Jr, et al. HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology 2010; 75:2087-96
2. McArthur JC, Hoover DR, Bacellar H, et al. Dementia in AIDS patients: incidence and risk factors. Multicenter AIDS Cohort Study. Neurology 1993; 43:2245-52
3. Heaton RK, Marcotte TD, Mindt MR, et al. The impact of HIVassociated neuropsychological impairment on everyday functioning. J Int Neuropsychol Soc 2004; 10:317-31
4. Tozzi V, Balestra P, Lorenzini P, et al. Prevalence and risk factors for human immunodeficiency virus-associated neurocognitive impairment, 1996 to 2002: results from an urban observational cohort. J Neurovirol 2005; 11:265-73
5. Ellis RJ, Moore DJ, Childers ME, et al. Progression to neuropsychological impairment in human immunodeficiency virus infection predicted by elevated cerebrospinal fluid levels of human immunodeficiency virus RNA. Arch Neurol 2002; 59:923-8
6. Shiramizu B, Gartner S, Williams A, et al. Circulating proviral HIV DNA and HIV-associated dementia. AIDS 2005; 19:45-52
7. Burdo TH, Soulas C, Orzechowski K, et al. Increased monocyte turnover from bone marrow correlates with severity of SIV encephalitis and CD163 levels in plasma. PLoS Pathog 2010; 6:e1000842
8. Liu Y, Tang XP, McArthur JC, Scott J, Gartner S. Analysis of human immunodeficiency virus type 1 gp160 sequences from a patient with HIV dementia: evidence for monocyte trafficking into brain. J Neurovirol 2000; 6(Suppl 1):S70-81
9. Fuller RA, Westmoreland SV, Ratai E, et al. A prospective longitudinal in vivo 1H MR spectroscopy study of the SIV/macaque model of neuroAIDS. BMC Neurosci 2004; 5:10
10. Resnick L, Berger JR, Shapshak P, Tourtellotte WW. Early penetration of the blood-brain-barrier by HIV. Neurology 1988; 38:9-14
11. Davis LE, Hjelle BL, Miller VE, et al. Early viral brain invasion in iatrogenic human immunodeficiency virus infection. Neurology 1992; 42:1736-9
12. Fiebig EW, Wright DJ, Rawal BD, et al. Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. Aids 2003; 17:1871-9
13. Ananworanich J, Phanuphak N, de Souza M, et al. Incidence and characterization of acute HIV-1 infection in a high-risk Thai population. J Acquir Immune Defic Syndr 2008; 49:151-5
14. Somnuek S, Techasathit W, Utaipiboon C, et al. Practice Guideline: Thai national guidelines for antiretroviral therapy in HIV-1 infected adults and adolescents. Asian Biomedicine 2010; 4:515-28
15. Valcour VG, Sithinamsuwan P, Nidhinandana S, et al. Neuropsychological abnormalities in patients with dementia in CRF 01 AE HIV-1 infection. Neurology 2007; 68:525-7
16. Arroyo MA, Phanuphak N, Krasaesub S, et al. HIV type 1 molecular epidemiology among high-risk clients attending the Thai Red Cross Anonymous Clinic in Bangkok, Thailand. AIDS Res Hum Retroviruses 2010; 26:5-12
17. Webb PG, Sailasuta N, Kohler SJ, Raidy T, Moats RA, Hurd RE. Automated single-voxel proton MRS: technical development and multisite verification. Magn Reson Med 1994; 31:365-73
18. Spudich S, Gisslen M, Hagberg L, et al. Central nervous system immune activation characterizes primary HIV-1 infection even in subjects with minimal cerebrospinal fluid viral burden. J Infect Dis 2011; 204:753-60
19. Smith MO, Heyes MP, Lackner AA. Early intrathecal events in rhesus macaques (Macaca mulatta) infected with pathogenic or nonpathogenic molecular clones of simian immunodeficiency virus. Lab Invest 1995; 72:547-58
20. Salazar-Gonzalez JF, Salazar MG, Keele BF, et al. Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection. J Exp Med 2009; 206:1273-89
21. Ranjbar S, Rajsbaum R, Goldfeld AE. Transactivator of transcription from HIV type 1 subtype E selectively inhibits TNF gene expression via interference with chromatin remodeling of the TNF locus. J Immunol 2006; 176:4182-90
22. Spudich SS, Nilsson AC, Lollo ND, et al. Cerebrospinal fluid HIV infection and pleocytosis: relation to systemic infection and antiretroviral treatment. BMC Infect Dis 2005; 5:98
23. Canestri A, Lescure FX, Jaureguiberry S, et al. Discordance between cerebral spinal fluid and plasma HIV replication in patients with neurological symptoms who are receiving suppressive antiretroviral therapy. Clin Infect Dis 2010; 50:773-8
24. Denning DW. The neurological features of acute HIV infection. Biomed Pharmacother 1988; 42:11-4
25. Vanhems P, Allard R, Cooper DA, et al. Acute human immunodeficiency virus type 1 disease as a mononucleosis-like illness: is the diagnosis too restrictive? Clin Infect Dis 1997; 24:965-70
26. Cinque P, Vago L, Mengozzi M, et al. Elevated cerebrospinal fluid levels of monocyte chemotactic protein-1 correlate with HIV-1 encephalitis and local viral replication. Aids 1998; 12:1327-32
27. Hagberg L, Cinque P, Gisslen M, et al. Cerebrospinal fluid neopterin: an informative biomarker of central nervous system immune activation in HIV-1 infection. AIDS Res Ther 2010; 7:15
28. Fuchs D, Spira TJ, Hausen A, et al. Neopterin as a predictive marker for disease progression in human immunodeficiency virus type 1 infection. Clin Chem 1989; 35:1746-9
29. Gonzalez-Scarano F, Martin-Garcia J. The neuropathogenesis of AIDS. Nat Rev Immunol 2005; 5:69-81
30. Salvan AM, Vion-Dury J, Confort-Gouny S, Nicoli F, Lamoureux S, Cozzone PJ. Brain proton magnetic resonance spectroscopy in HIVrelated encephalopathy: identification of evolving metabolic patterns in relation to dementia and therapy. AIDS Res Hum Retroviruses 1997; 13:1055-66
31. Greco JB, Westmoreland SV, Ratai EM, et al. In vivo 1H MRS of brain injury and repair during acute SIV infection in the macaque model of neuroAIDS. Magn Reson Med 2004; 51:1108-14
32. Bell SK, Little SJ, Rosenberg ES. Clinical management of acute HIV infection: best practice remains unknown. J Infect Dis 2010; 202 (Suppl 2):S278-88